Nickel, Kathrin
Tebartz van Elst, Ludger
Domschke, Katharina
Gläser, Birgitta
Stock, Friedrich
Endres, Dominique
Maier, Simon
Riedel, Andreas
Article History
Received: 28 November 2017
Accepted: 19 July 2018
First Online: 2 August 2018
Authors’ information
: Not applicable.
: Written informed consent was obtained from the parents of the patient for the case report.
: Written informed consent was obtained from the parents of the patient for publication of the case report.
: Kathrin Nickel: no conflict of interest. Ludger Tebartz van Elst has received advisory boards, lectures, or travel grants within the last 3 years: Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. Katharina Domschke: no conflict of interest. Birgitta Gläser: no conflict of interest. Friedrich Stock: no conflict of interest. Dominique Endres: no conflict of interest. Simon Maier: no conflict of interest. Andreas Riedel: no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.